183 related articles for article (PubMed ID: 38656242)
21. Current status of diagnosis and treatment of advanced non-small cell lung cancer in China during the COVID-19 pandemic.
Liu M; Zhao W; Li S; Chen L; Zhou C
Ann Palliat Med; 2022 Apr; 11(4):1231-1240. PubMed ID: 34894701
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.
Türk SM; Öztürk Z; Karataş D; Erkorkmaz Ü; Gönüllü E
Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161620
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as mortality predictor of advanced stage non-small cell lung cancer (NSCLC) with COVID-19 in Indonesia.
Sutandyo N; Jayusman AM; Widjaja L; Dwijayanti F; Imelda P; Hanafi AR
Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3868-3878. PubMed ID: 34109595
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 in patients with lung cancer.
Luo J; Rizvi H; Preeshagul IR; Egger JV; Hoyos D; Bandlamudi C; McCarthy CG; Falcon CJ; Schoenfeld AJ; Arbour KC; Chaft JE; Daly RM; Drilon A; Eng J; Iqbal A; Lai WV; Li BT; Lito P; Namakydoust A; Ng K; Offin M; Paik PK; Riely GJ; Rudin CM; Yu HA; Zauderer MG; Donoghue MTA; Łuksza M; Greenbaum BD; Kris MG; Hellmann MD
Ann Oncol; 2020 Oct; 31(10):1386-1396. PubMed ID: 32561401
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
[TBL] [Abstract][Full Text] [Related]
26. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
27. Racial and Ethnic Disparities in Disease Severity on Admission Chest Radiographs among Patients Admitted with Confirmed Coronavirus Disease 2019: A Retrospective Cohort Study.
Joseph NP; Reid NJ; Som A; Li MD; Hyle EP; Dugdale CM; Lang M; Betancourt JR; Deng F; Mendoza DP; Little BP; Narayan AK; Flores EJ
Radiology; 2020 Dec; 297(3):E303-E312. PubMed ID: 32673191
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
29. Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
Liu SP; Zhang Q; Wang W; Zhang M; Liu C; Xiao X; Liu Z; Hu WM; Jin P
Diabetes Res Clin Pract; 2020 Sep; 167():108338. PubMed ID: 32712122
[TBL] [Abstract][Full Text] [Related]
30. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP; De Rossi N; Schiavetti I; Carmisciano L; Cordioli C; Moiola L; Radaelli M; Immovilli P; Capobianco M; Trojano M; Zaratin P; Tedeschi G; Comi G; Battaglia MA; Patti F; Salvetti M;
Ann Neurol; 2021 Apr; 89(4):780-789. PubMed ID: 33480077
[TBL] [Abstract][Full Text] [Related]
31. The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
Li M; Wang Y; Ndiwane N; Orner MB; Palacios N; Mittler B; Berlowitz D; Kazis LE; Xia W
PLoS One; 2021; 16(3):e0248652. PubMed ID: 33735262
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study.
Gude-Sampedro F; Fernández-Merino C; Ferreiro L; Lado-Baleato Ó; Espasandín-Domínguez J; Hervada X; Cadarso CM; Valdés L
Int J Epidemiol; 2021 Mar; 50(1):64-74. PubMed ID: 33349845
[TBL] [Abstract][Full Text] [Related]
33. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
Hakeam HA; Alsemari M; Duhailib ZA; Ghonem L; Alharbi SA; Almutairy E; Sheraim NMB; Alsalhi M; Alhijji A; AlQahtani S; Khalid M; Barry M
J Cardiovasc Pharmacol Ther; 2021 May; 26(3):244-252. PubMed ID: 33231487
[TBL] [Abstract][Full Text] [Related]
34. Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Friedlaender A; Metro G; Signorelli D; Gili A; Economopoulou P; Roila F; Banna G; De Toma A; Camerini A; Christopoulou A; Lo Russo G; Banini M; Galetta D; Jimenez B; Collazo-Lorduy A; Calles A; Baxevanos P; Linardou H; Kosmidis P; Mountzios G; Garassino MC; Addeo A
Acta Oncol; 2020 Sep; 59(9):1058-1063. PubMed ID: 32762415
[No Abstract] [Full Text] [Related]
35. Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.
Kim YJ; Kim MJ; Cho YJ; Park JS; Kim JW; Chang H; Lee JO; Lee KW; Kim JH; Yoon HI; Bang SM; Lee JH; Lee CT; Lee JS
Med Oncol; 2014 Mar; 31(3):847. PubMed ID: 24448977
[TBL] [Abstract][Full Text] [Related]
36. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.
Espiritu AI; Chiu HHC; Sy MCC; Anlacan VMM; ; Jamora RDG
Sci Rep; 2021 Dec; 11(1):24436. PubMed ID: 34952903
[TBL] [Abstract][Full Text] [Related]
37. Association between the degree of obstructive sleep apnea and the severity of COVID-19: An explorative retrospective cross-sectional study.
Ho JPTF; Donders HCM; Zhou N; Schipper K; Su N; de Lange J
PLoS One; 2021; 16(9):e0257483. PubMed ID: 34529732
[TBL] [Abstract][Full Text] [Related]
38. Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial.
Li SY; Li Q; Guan WJ; Huang J; Yang HP; Wu GM; Jin FG; Hu CP; Chen LA; Xu GL; Liu SZ; Wu CG; Han BH; Xiang Y; Zhao JP; Wang J; Zhou X; Li HP; Zhong NS
Lung Cancer; 2016 Aug; 98():43-50. PubMed ID: 27393505
[TBL] [Abstract][Full Text] [Related]
39. Better COVID-19 Intensive Care Unit survival in females, independent of age, disease severity, comorbidities, and treatment.
Meijs DAM; van Bussel BCT; Stessel B; Mehagnoul-Schipper J; Hana A; Scheeren CIE; Peters SAE; van Mook WNKA; van der Horst ICC; Marx G; Mesotten D; Ghossein-Doha C;
Sci Rep; 2022 Jan; 12(1):734. PubMed ID: 35031644
[TBL] [Abstract][Full Text] [Related]
40. Six-month prognosis of patients with lung cancer admitted to the intensive care unit.
Roques S; Parrot A; Lavole A; Ancel PY; Gounant V; Djibre M; Fartoukh M
Intensive Care Med; 2009 Dec; 35(12):2044-50. PubMed ID: 19768453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
